176 related articles for article (PubMed ID: 35507829)
1. Comparative effectiveness of cognitive behavioral treatment, serotonin, and serotonin noradrenaline reuptake inhibitors for anxiety in children and adolescents: a network meta-analysis.
Arnardóttir A; Skarphedinsson G
Nord J Psychiatry; 2023 Feb; 77(2):118-126. PubMed ID: 35507829
[TBL] [Abstract][Full Text] [Related]
2. Comparative Effectiveness and Safety of Cognitive Behavioral Therapy and Pharmacotherapy for Childhood Anxiety Disorders: A Systematic Review and Meta-analysis.
Wang Z; Whiteside SPH; Sim L; Farah W; Morrow AS; Alsawas M; Barrionuevo P; Tello M; Asi N; Beuschel B; Daraz L; Almasri J; Zaiem F; Larrea-Mantilla L; Ponce OJ; LeBlanc A; Prokop LJ; Murad MH
JAMA Pediatr; 2017 Nov; 171(11):1049-1056. PubMed ID: 28859190
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of serotonin reuptake inhibitors (SSRI) and serotonin noradrenaline reuptake inhibitors (SNRI) for children and adolescents with anxiety disorders: a systematic review and meta-analysis.
Stefánsdóttir ÍH; Ivarsson T; Skarphedinsson G
Nord J Psychiatry; 2023 Feb; 77(2):137-146. PubMed ID: 35587815
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of cognitive behavioral therapy (CBT) for child and adolescent anxiety disorders across different CBT modalities and comparisons: a systematic review and meta-analysis.
Sigurvinsdóttir AL; Jensínudóttir KB; Baldvinsdóttir KD; Smárason O; Skarphedinsson G
Nord J Psychiatry; 2020 Apr; 74(3):168-180. PubMed ID: 31738631
[No Abstract] [Full Text] [Related]
5. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis.
Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA
PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of cognitive behaviour therapy and selective serotonin reuptake inhibitors for the treatment of hypochondriasis: Implications for trial design.
Fineberg NA; Pellegrini L; Clarke A; Perera U; Drummond LM; Albert U; Laws KR
Compr Psychiatry; 2022 Oct; 118():152334. PubMed ID: 36007340
[TBL] [Abstract][Full Text] [Related]
7. Advances in Pharmacotherapy for Pediatric Anxiety Disorders.
Nicotra CM; Strawn JR
Child Adolesc Psychiatr Clin N Am; 2023 Jul; 32(3):573-587. PubMed ID: 37201968
[TBL] [Abstract][Full Text] [Related]
8. Trajectory and magnitude of response in adults with anxiety disorders: a Bayesian hierarchical modeling meta-analysis of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and benzodiazepines.
Mendez EM; Mills JA; Suresh V; Stimpfl JN; Strawn JR
CNS Spectr; 2024 Jun; 29(3):187-196. PubMed ID: 38523533
[TBL] [Abstract][Full Text] [Related]
9. Incidence of adverse events and comparative tolerability of selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for the treatment of anxiety, obsessive-compulsive, and stress disorders: a systematic review and network meta-analysis.
Gosmann NP; Costa MA; Jaeger MB; Frozi J; Spanemberg L; Manfro GG; Cortese S; Cuijpers P; Pine DS; Salum GA
Psychol Med; 2023 Jul; 53(9):3783-3792. PubMed ID: 37278215
[TBL] [Abstract][Full Text] [Related]
10. Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders.
Walter HJ; Bukstein OG; Abright AR; Keable H; Ramtekkar U; Ripperger-Suhler J; Rockhill C
J Am Acad Child Adolesc Psychiatry; 2020 Oct; 59(10):1107-1124. PubMed ID: 32439401
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A Meta-Analysis.
Strawn JR; Mills JA; Sauley BA; Welge JA
J Am Acad Child Adolesc Psychiatry; 2018 Apr; 57(4):235-244.e2. PubMed ID: 29588049
[TBL] [Abstract][Full Text] [Related]
12. Combining selective serotonin reuptake inhibitors and cognitive behavioral therapy in youth with depression and anxiety.
Strawn JR; Mills JA; Suresh V; Peris TS; Walkup JT; Croarkin PE
J Affect Disord; 2022 Feb; 298(Pt A):292-300. PubMed ID: 34728290
[TBL] [Abstract][Full Text] [Related]
13. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.
Jakubovski E; Johnson JA; Nasir M; Müller-Vahl K; Bloch MH
Depress Anxiety; 2019 Mar; 36(3):198-212. PubMed ID: 30479005
[TBL] [Abstract][Full Text] [Related]
14. Neural mechanisms and predictors of SSRI and CBT treatment of anxiety: A randomized trial focused on emotion and cognitive processing.
Kinney KL; Burkhouse KL; Chang F; MacNamara A; Klumpp H; Phan KL
J Anxiety Disord; 2021 Aug; 82():102449. PubMed ID: 34274600
[TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
[TBL] [Abstract][Full Text] [Related]
16. Six decades of preventing and treating childhood anxiety disorders: a systematic review and meta-analysis to inform policy and practice.
Schwartz C; Barican JL; Yung D; Zheng Y; Waddell C
Evid Based Ment Health; 2019 Aug; 22(3):103-110. PubMed ID: 31315926
[TBL] [Abstract][Full Text] [Related]
17. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children/adolescents and adults.
Skapinakis P; Caldwell D; Hollingworth W; Bryden P; Fineberg N; Salkovskis P; Welton N; Baxter H; Kessler D; Churchill R; Lewis G
Health Technol Assess; 2016 Jun; 20(43):1-392. PubMed ID: 27306503
[TBL] [Abstract][Full Text] [Related]
19. Antidepressants for people with epilepsy and depression.
Maguire MJ; Marson AG; Nevitt SJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
